Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18462575 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
Condition: Macular Degeneration
Interventions: Drug: bevacizumab;   Drug: vetaporfin

Indicates status has not been verified in more than two years